Sugden PH |
Signalling pathways in cardiac myocyte hypertrophy. |
2001 |
Ann. Med. |
pmid:11817656
|
Sun L et al. |
Cellular and molecular consequences of calcineurin A alpha gene deletion. |
2007 |
Ann. N. Y. Acad. Sci. |
pmid:17872390
|
Shipston MJ et al. |
Glucocorticoid negative feedback in pituitary corticotropes. Pivotal role for calcineurin inhibition of adenylyl cyclase. |
1994 |
Ann. N. Y. Acad. Sci. |
pmid:7529975
|
Iwanaga Y et al. |
Living donor islet transplantation, the alternative approach to overcome the obstacles limiting transplant. |
2006 |
Ann. N. Y. Acad. Sci. |
pmid:17130575
|
Xu L et al. |
Potential for pharmacology of ryanodine receptor/calcium release channels. |
1998 |
Ann. N. Y. Acad. Sci. |
pmid:10603942
|
Bers DM et al. |
Factors that control sarcoplasmic reticulum calcium release in intact ventricular myocytes. |
1998 |
Ann. N. Y. Acad. Sci. |
pmid:10603944
|
Engelbrecht ME et al. |
The effect of immunosuppressants on human leukocyte NADPH oxidase. |
1994 |
Ann. N. Y. Acad. Sci. |
pmid:7518204
|
Zuany-Amorim C et al. |
Modulation by rm interferon-gamma and CD4+ T-lymphocytes of allergic eosinophil accumulation in the mice peritoneal cavity. |
1994 |
Ann. N. Y. Acad. Sci. |
pmid:7518212
|
Nagai H et al. |
The role of interleukin-5 (IL-5) in allergic airway hyperresponsiveness in mice. |
1996 |
Ann. N. Y. Acad. Sci. |
pmid:8906215
|
Clipstone NA and Crabtree GR |
Calcineurin is a key signaling enzyme in T lymphocyte activation and the target of the immunosuppressive drugs cyclosporin A and FK506. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7509131
|
Takahara S |
Efficacy of FK506 in renal transplantation. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7509132
|
Thomson AW et al. |
Incidence of CD4+ IL-2R alpha+ and CD4+ CD45RA+ T-cells in progressive multiple sclerosis and the influence of short-term (3 months) FK 506 therapy. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7509133
|
Lemster B et al. |
FK 506 inhibits cytokine gene and adhesion molecule expression in psoriatic skin lesions. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7509134
|
Tamura K et al. |
Inhibitory effect of FK 506 on autoimmune thyroid disease in the PVG rat. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7509135
|
Ochiai T et al. |
Combination of immunosuppressive drugs for organ transplantation. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7509136
|
Wiederrecht G et al. |
The mechanism of action of FK-506 and cyclosporin A. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7509138
|
Lee RK and Wurtman RJ |
Regulation of APP synthesis and secretion by neuroimmunophilin ligands and cyclooxygenase inhibitors. |
2000 |
Ann. N. Y. Acad. Sci. |
pmid:11193162
|
Christensen BG |
FK-506: its role in immunosuppression. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689803
|
Kino T and Goto T |
Discovery of FK-506 and update. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689804
|
Parsons WH et al. |
FK-506--a novel immunosuppressant. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689805
|
Zenke G et al. |
Molecular mechanisms of immunosuppression by cyclosporins. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689806
|
Clardy J |
Structural studies of complexed FK-506 binding protein. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689808
|
Starzl TE et al. |
Allograft and xenograft acceptance under FK-506 and other immunosuppressant treatment. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689809
|
Reem GH et al. |
FK-506 inhibits the IL-2-independent induction of the activation antigen CD 69. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689811
|
Mollison KW et al. |
Comparison of FK-506, rapamycin, ascomycin, and cyclosporine in mouse models of host-versus-graft disease and heterotopic heart transplantation. |
1993 |
Ann. N. Y. Acad. Sci. |
pmid:7689812
|
Ponseti JM et al. |
Tacrolimus for myasthenia gravis: a clinical study of 212 patients. |
2008 |
Ann. N. Y. Acad. Sci. |
pmid:18096852
|
Paterson DL et al. |
Could a herpesvirus mimic tacrolimus-induced leukoencephalopathy? |
1997 |
Ann. Neurol. |
pmid:9266742
|
Caprariello AV et al. |
Apoptosis of oligodendrocytes in the central nervous system results in rapid focal demyelination. |
2012 |
Ann. Neurol. |
pmid:23034912
|
Keswani SC et al. |
FK506 is neuroprotective in a model of antiretroviral toxic neuropathy. |
2003 |
Ann. Neurol. |
pmid:12509848
|
Dawson TM |
Immunosuppressants, immunophilins, and the nervous system. |
1996 |
Ann. Neurol. |
pmid:8871573
|
Small SL et al. |
Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506) |
1996 |
Ann. Neurol. |
pmid:8871576
|
Roberts WK et al. |
A destructive feedback loop mediated by CXCL10 in central nervous system inflammatory disease. |
2015 |
Ann. Neurol. |
pmid:26224283
|
Wijdicks EF et al. |
FK506-induced neurotoxicity in liver transplantation. |
1994 |
Ann. Neurol. |
pmid:7512320
|
Nelson M et al. |
Direct revascularization is superior for rat parathyroid allotransplantation with FK506. |
2005 |
Ann. Otol. Rhinol. Laryngol. |
pmid:15825570
|
Gerster JC et al. |
Gout in liver transplant patients receiving tacrolimus. |
2004 |
Ann. Rheum. Dis. |
pmid:15194597
|
Igarashi T et al. |
Central nervous system toxicity related to FK506 in patients with Behçet's disease. |
1994 |
Ann. Rheum. Dis. |
pmid:7517134
|
Villaverde V et al. |
Leg bone pain syndrome in a kidney transplant patient treated with tacrolimus (FK506) |
1999 |
Ann. Rheum. Dis. |
pmid:10577370
|
Duddridge M and Powell RJ |
Treatment of severe and difficult cases of systemic lupus erythematosus with tacrolimus. A report of three cases. |
1997 |
Ann. Rheum. Dis. |
pmid:9462174
|
Lightman S et al. |
Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17. |
2015 |
Ann. Rheum. Dis. |
pmid:25269831
|
Lampropoulos CE and D' Cruz DP |
Topical tacrolimus treatment in a patient with dermatomyositis. |
2005 |
Ann. Rheum. Dis. |
pmid:16100347
|
Mok CC et al. |
Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up. |
2016 |
Ann. Rheum. Dis. |
pmid:25550339
|
Lerut JP et al. |
Is minimal, [almost] steroid-free immunosuppression a safe approach in adult liver transplantation? Long-term outcome of a prospective, double blind, placebo-controlled, randomized, investigator-driven study. |
2014 |
Ann. Surg. |
pmid:25379858
|
Schlegel A et al. |
Hypothermic Oxygenated Perfusion (HOPE) downregulates the immune response in a rat model of liver transplantation. |
2014 |
Ann. Surg. |
pmid:25243553
|
Colombani PM et al. |
Liver transplantation in infants younger than 1 year of age. |
1996 |
Ann. Surg. |
pmid:8645039
|
Todo S et al. |
Liver, kidney, and thoracic organ transplantation under FK 506. |
1990 |
Ann. Surg. |
pmid:1697743
|
Stratta RJ et al. |
Evolution in pancreas transplantation techniques: simultaneous kidney-pancreas transplantation using portal-enteric drainage without antilymphocyte induction. |
1999 |
Ann. Surg. |
pmid:10235529
|
Shapiro R et al. |
Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. |
2003 |
Ann. Surg. |
pmid:14530723
|
Fealy MJ et al. |
Efficacy of rapamycin and FK 506 in prolonging rat hind limb allograft survival. |
1994 |
Ann. Surg. |
pmid:7507657
|
Ozawa K et al. |
An appraisal of pediatric liver transplantation from living relatives. Initial clinical experiences in 20 pediatric liver transplantations from living relatives as donors. |
1992 |
Ann. Surg. |
pmid:1280074
|
Vivarelli M et al. |
Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence. |
2008 |
Ann. Surg. |
pmid:18948815
|
Abu-Elmagd K et al. |
Clinical intestinal transplantation: a decade of experience at a single center. |
2001 |
Ann. Surg. |
pmid:11524593
|
Petruzzo P et al. |
Outcomes after bilateral hand allotransplantation: a risk/benefit ratio analysis. |
2015 |
Ann. Surg. |
pmid:24646555
|
Todo S et al. |
Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. |
1994 |
Ann. Surg. |
pmid:7522431
|
Jain A et al. |
What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients. |
1999 |
Ann. Surg. |
pmid:10493490
|
Lerut J et al. |
Tacrolimus monotherapy in liver transplantation: one-year results of a prospective, randomized, double-blind, placebo-controlled study. |
2008 |
Ann. Surg. |
pmid:19092340
|
Schneeberger S et al. |
Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. |
2013 |
Ann. Surg. |
pmid:23001085
|
Bartlett ST et al. |
Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation. A prospective trial of tacrolimus immunosuppression with percutaneous biopsy. |
1996 |
Ann. Surg. |
pmid:8857849
|
Todo S et al. |
Intestinal transplantation in composite visceral grafts or alone. |
1992 |
Ann. Surg. |
pmid:1384443
|
Sho M et al. |
New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs. |
2002 |
Ann. Surg. |
pmid:12409674
|
McCourtie AS et al. |
Synergistic protection in lung ischemia-reperfusion injury with calcineurin and thrombin inhibition. |
2010 |
Ann. Thorac. Surg. |
pmid:20494024
|
Laubach VE |
Invited commentary. |
2010 |
Ann. Thorac. Surg. |
pmid:20494025
|
Li S et al. |
Intrathymic inoculation of donor bone marrow induces long-term acceptance of lung allografts. |
2003 |
Ann. Thorac. Surg. |
pmid:12537225
|
Sugita M et al. |
Pharmacologic modulation of alveolar liquid clearance in transplanted lungs by phentolamine and FK506. |
2009 |
Ann. Thorac. Surg. |
pmid:19699927
|
Moffatt-Bruce S |
Invited commentary. |
2009 |
Ann. Thorac. Surg. |
pmid:19699928
|
Thyagarajan GK et al. |
FK506-induced fulminant leukoencephalopathy after single-lung transplantation. |
1997 |
Ann. Thorac. Surg. |
pmid:9386723
|
Leshnower BG et al. |
Cyclosporine preserves mitochondrial morphology after myocardial ischemia/reperfusion independent of calcineurin inhibition. |
2008 |
Ann. Thorac. Surg. |
pmid:18805178
|
Chambers DJ |
Invited commentary. |
2008 |
Ann. Thorac. Surg. |
pmid:18805179
|
Nathan M et al. |
Cyclosporin A but not FK-506 protects against dopamine-induced apoptosis in the stunned heart. |
2005 |
Ann. Thorac. Surg. |
pmid:15854943
|
Hirai T et al. |
A short course of FK506 can induce limited donor-specific graft acceptance. |
1994 |
Ann. Thorac. Surg. |
pmid:7520685
|
Armitage JM et al. |
Clinical trial of FK 506 immunosuppression in adult cardiac transplantation. |
1992 |
Ann. Thorac. Surg. |
pmid:1379032
|
Oto T et al. |
Calcineurin inhibitor-related cholestasis complicating lung transplantation. |
2010 |
Ann. Thorac. Surg. |
pmid:20417810
|
Groetzner J et al. |
Cardiac transplantation in pediatric patients: fifteen-year experience of a single center. |
2005 |
Ann. Thorac. Surg. |
pmid:15620914
|
Inutsuka K et al. |
Reconstruction of trachea and carina with immediate or cryopreserved allografts in dogs. |
1996 |
Ann. Thorac. Surg. |
pmid:8893587
|
Bolman RM |
Advantage--FK 506: reduced chronic rejection for lung transplant recipients. |
1995 |
Ann. Thorac. Surg. |
pmid:7545888
|
Keenan RJ et al. |
Clinical trial of tacrolimus versus cyclosporine in lung transplantation. |
1995 |
Ann. Thorac. Surg. |
pmid:7545889
|
Wilson CH et al. |
Prospective randomised trial of the use of Daclizumab in renal transplantation using kidneys from non heart beating donors. |
2004 |
Ann. Transplant. |
pmid:15478912
|
Boratyńska M et al. |
Conversion from cyclosporine-based immunosuppression to tacrolimus/mycophenolate mofetil in patients with refractory and ongoing acute renal allograft rejection. |
2006 |
Ann. Transplant. |
pmid:17494290
|
Grochowiecki T et al. |
A retrospective study of steroid elimination in simultaneous pancreas and preemptive kidney transplant (Sppre-Ktx) recipients. |
2006 |
Ann. Transplant. |
pmid:17494291
|
Rhu J et al. |
Clinical Implication of Mycophenolic Acid Trough Concentration Monitoring in Kidney Transplant Patients on a Tacrolimus Triple Maintenance Regimen: A Single-Center Experience. |
2017 |
Ann. Transplant. |
pmid:29180612
|
Mocchegiani F et al. |
Tacrolimus and Everolimus de novo versus minimization of standard dosage of Tacrolimus provides a similar renal function at one year after liver transplantation: a case-control matched-pairs analysis. |
2014 |
Ann. Transplant. |
pmid:25347718
|
Rehman S et al. |
Effect of different tacrolimus levels on early outcomes after kidney transplantation. |
2014 |
Ann. Transplant. |
pmid:24509826
|
Hakeam HA et al. |
Sirolimus induced dyslipidemia in tacrolimus based vs. tacrolimus free immunosuppressive regimens in renal transplant recipients. |
2008 |
Ann. Transplant. |
pmid:18566560
|
Furmańczyk A et al. |
Atypical calcineurin inhibitor-induced haemolytic uremic syndrome after liver transplantation. |
2009 Oct-Dec |
Ann. Transplant. |
pmid:20009155
|
Gerlach UA et al. |
Aspergillus spondylodiscitis after multivisceral transplantation. |
2009 Oct-Dec |
Ann. Transplant. |
pmid:20009156
|
Malinowski M et al. |
Effect of tacrolimus dosing on glucose metabolism in an experimental rat model. |
2010 Jul-Sep |
Ann. Transplant. |
pmid:20877268
|
Miyata Y et al. |
Pharmacokinetics of a Once-Daily Dose of Tacrolimus Early After Liver Transplantation: With Special Reference to CYP3A5 and ABCB1 Single Nucleotide Polymorphisms. |
2016 |
Ann. Transplant. |
pmid:27503662
|
Mizuno S et al. |
Combination assays for evaluation of immune function and CYP3A5 genotype to identify the risk of infectious complications and mortality in living donor liver transplant patients. |
2013 |
Ann. Transplant. |
pmid:23845965
|
Herden U et al. |
Early Initiation of Everolimus After Liver Transplantation: A Single-Center Experience. |
2016 |
Ann. Transplant. |
pmid:26842532
|
Kuypers DR |
Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring. |
2008 |
Ann. Transplant. |
pmid:18806728
|
Grenda R et al. |
Evaluation of the genetic background of standard-immunosuppressant-related toxicity in a cohort of 200 paediatric renal allograft recipients--a retrospective study. |
2009 Jul-Sep |
Ann. Transplant. |
pmid:19644155
|
Fukazawa K et al. |
Central pontine myelinolysis (CPM) associated with tacrolimus (FK506) after liver transplantation. |
2011 Jul-Sep |
Ann. Transplant. |
pmid:21959523
|
Ogura Y et al. |
Early Conversion From Twice-Daily Tacrolimus to Prolonged-Release Tacrolimus in Liver Transplantation: A Single-Center Experience. |
2016 |
Ann. Transplant. |
pmid:27432248
|
Dedinská I et al. |
Waist circumference as an independent risk factor for NODAT. |
2015 |
Ann. Transplant. |
pmid:25791039
|
Rostaing L et al. |
The pharmacokinetics of everolimus in de novo kidney transplant patients receiving tacrolimus: an analysis from the randomized ASSET study. |
2014 |
Ann. Transplant. |
pmid:25017487
|
Provenzani A et al. |
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in Caucasian liver transplant patients. |
2009 Jan-Mar |
Ann. Transplant. |
pmid:19289993
|
Wu P et al. |
Polymorphisms in CYP3A5*3 and MDR1, and haplotype modulate response to plasma levels of tacrolimus in Chinese renal transplant patients. |
2011 Jan-Mar |
Ann. Transplant. |
pmid:21436775
|
Schnitzbauer AA et al. |
Delayed bottom-up and amended simple method of dosing with once-daily tacrolimus application to achieve stable trough levels in liver transplantation. |
2015 |
Ann. Transplant. |
pmid:25553853
|
Garlicki M et al. |
Conversion from cyclosporine to tacrolimus improves renal function and lipid profile after cardiac transplantation. |
2006 |
Ann. Transplant. |
pmid:17025026
|
Van Laecke S et al. |
Effect of Magnesium Supplements on Insulin Secretion After Kidney Transplantation: A Randomized Controlled Trial. |
2017 |
Ann. Transplant. |
pmid:28848225
|
Thölking G et al. |
Tacrolimus Concentration/Dose Ratio is Associated with Renal Function After Liver Transplantation. |
2016 |
Ann. Transplant. |
pmid:27003330
|